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Abstract: In this work, a molecular modeling and multivariate study involving 
artemisinin and 28 derivatives with activity against human hepatocellular carci-
noma HepG2 is reported. The studied calculations of the compounds were per-
formed at the B3LYP/6-31G
 level. MEP maps were used in an attempt to iden-
tify key structural features of artemisinin and its derivatives that are necessary for 
their activities, and to investigate their interaction with the transferrin. The chemo-
metrics methods PCA, HCA, KNN, SIMCA and SDA were employed in order to 
reduce dimensionality and to investigate which subset of variables could be more 
effective for classification of the compounds according to their degree of anticancer 
activity. Chemometric studies revealed that the ALOGPS_logs, Mor29m, IC5 and 
the gap energy descriptors are responsible for the separation into more active and 
less active compounds. In addition, molecular docking was used to investigate the 
interaction between ligands and receptor. The results showed that the ligands 
approached the receptor through the endoperoxide bond. 
Keywords: artemisinin; HepG2; MEP maps; chemometrics; molecular docking. 
INTRODUCTION 
Cancer, malignant neoplasia and malignant tumor are synonymous words for 
the disease characterized by uncontrolled growth of abnormal cells of an orga-
nism. The presence of some characteristics in these cells indicates alteration in 
genes owing to mutation in DNA.1 
                                                                                                                    
* Corresponding author. E-mail: jardelquantun@yahoo.com.br 
doi: 10.2298/JSC111227111B 
_________________________________________________________________________________________________________________________
2011 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/1264 BARBOSA  et al. 
According to the WHO, in 2008, the total number of new cases of cancer 
would reach 12.3 million people, with 7.6 million deaths. The least developed 
regions are more affected, considering both incidence (56 %) and mortality (63 
%).2 Most deaths are due to lung cancer (≈18.2 %), stomach cancer (≈9.7 %) and 
liver cancer (≈9.2 %). It is important to state that among the malignant tumors in 
the liver, the most common and dangerous one is the hepatocellular carcinoma.2 
Thus, it is essential to discover new efficient strategies to treat the disease and to 
avoid new cases. 
Artemisia annua L. (qinghao) is one of the plants that have shown anticancer 
properties. It contains the active ingredient artemisinin, which is used as an anti-
malarial, mainly against falciparum and vivax malaria.3–6 Lately, the sensitivity 
to artemisinin and its first generation derivatives artesunate, artemether, arteether 
and artelinate has been evaluated in some tumoral cells. It was verified that arte-
misinin and its derivatives exhibit cytotoxicity to mammary cell in nanomolar 
and micromolar concentrations.7 Moreover, low concentrations of these com-
pounds show cytotoxicity to leukemia cells, colon cancer, lung cancer, kidney 
cancer,8 thyroid cancer,9 cervical cancer, uterine cancer and ovarian cancer.10  
Another aspect that has intensified research with artemisinin and its deri-
vatives in anticancer treatment is the lack of resistance that tumoral cells show to 
these compounds. As a strategy to preserve natural sources of Artemisia annua L., 
endoperoxides similar to artemisinin were synthesized.11 Some of these second 
generation compounds showed considerable cytotoxicity to tumoral cells.12–16 
In this report, a molecular modeling and chemometric study of 29 artemisi-
nins (artemisinin and its derivatives) with different degrees of cytotoxicities 
against human hepatocellular carcinoma HepG2 is presented.17 The employed 
strategy was based on the knowledge that the endoperoxide group presented in 
artemisinin and its derivatives is responsible for their antimalarial and anticancer 
activities. Calculations of the studied molecules were performed by the 
B3LYP/6-31G
 method as implemented in the Gaussian 98 program.18 MEP 
maps were used in an attempt to identify key structural features of the artemisinin 
and the derivatives that are necessary for their activities and to investigate the in-
teraction with a molecular receptor (transferrin). PC and HC analyses, KNN and 
SIMCA methods19 and SD analysis20,21 were employed in order to reduce di-
mensionality and to investigate which subset of variables could be more effective 
at classifying the compounds according to their degree of anticancer activity. 
Molecular docking studies were used to investigate the interaction between the 
ligands and receptor (transferrin). The developed studies could provide valuable 
insight into the experimental process of syntheses and biological evaluation of 
new artemisinin derivatives with activity against cancer HepG2. 
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COMPUTATIONAL 
Modeled artemisinin and derivatives 
The compounds, the subjects of this study, consisted of artemisinin, amides, esters, 
alcohols, ketones, derivatives with polar hydroxyl and carboxylic acid groups and five-mem-
bered ring derivatives. All compounds have been associated with in vitro bioactivity against a 
human hepatocellular carcinoma cell line, HepG2, and were divided previously into two 
classes according with their activities: (–) less active (those with IC50 ≥ 97 μM) and (+) more 
active (those with IC50 < 97 μM) derivatives. The atom numbering adopted in this study is 
showed in Fig. 1 (artemisinin 1). 
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Fig. 1. Artemisinin and derivatives with anticancer HepG2 activity. 
Molecular modeling 
Quantum chemical approaches implemented in the Gaussian 98 program were used in 
the modeling of the artemisinin derivatives. Initially, the artemisinin geometry optimization 
was performed by Hartree-Fock (HF) method22 and Density Functional Theory (B3LYP)23,24 
with the 3-21G, 6-31G, 6-31G
, 6-31G
, CEP-31G and CEP-31G
 basis sets and AM1 and 
PM3 methods, also available in the Gaussian program.18 These calculations were performed to 
find the method that would present the best compromise between computational time and 
accuracy of the information relative to experimental data.25 The experimental structure of 
artemisinin was retrieved from the Cambridge Structural Database CSD26 with REFCODES: 
QNGHSU10,25 crystallographic R factor 3.6. 
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Chemometric methods implemented in the Pirouette program,27 PCA and HCA, were 
used to compare the optimized structures by different approaches with the experimental struc-
ture of artemisinin QNGHSU to identify the appropriate method and the basis set for further 
calculations. The analyses were performed on an autoscaled data matrix with dimension 
15×18, where each row was related to 14 computed and 1 experimental geometries and each 
column represented one of 18 geometrical parameters of the 1,2,4-trioxane ring (bond lengths, 
bond angles and torsion angles). In order to optimize all structures and to perform calculations 
to obtain the molecular properties, the B3LYP/6-31G
 method was also selected. 
Molecular descriptors 
The descriptors were computed to represent electronic, steric as well as hydrophilic and 
hydrophobic features, and to allow for quantification of their influence on the biological 
activity of the studied molecules. The electronic descriptors employed were: total energy, 
HOMO, HOMO–1, LUMO, LUMO+1 energies, LUMO–HOMO gap energy, Mulliken’s 
electronegativity, and molecular hardness and softness; the steric descriptors were: O1–O2 
bond length, C12a–O1–O2–C3 torsion angle, superficial area, molecular volume, Mor29m 
and IC5; the hydrophilic descriptors were: HYF,  ALOGPS_logs and the hydrophobic 
descriptor was the log P value. The computation of the descriptors was performed employing 
the Gaussian 98 program, the e-Dragon program28 and the HyperChem 6.02. program.29 
Molecular electrostatic potential maps  
The MEP is related to the electronic density and it is a very useful descriptor to under-
stand sites for electrophilic attack and nucleophilic reactions as well as for hydrogen bonding 
interactions.30–33 The electrostatic potential, V(r), is also well-suited for analyzing processes 
based on the “recognition” of one molecule by another, as in drug–receptor, and enzyme– 
–substrate interactions, because it is through their potentials that the two species first “see” 
each other.34,35 Being a real physical property, V(r) can be determined experimentally by 
diffraction or by computational methods.36 To investigate the reactive sites of artemisinin and 
its derivatives, the MEP was evaluated using the B3LYP/6-31G
 method. The MEP at a 
given point (x,y,z) in the vicinity of a molecule is defined in terms of the interaction energy 
between the electrical charge generated from the molecule’s electrons and nuclei and a posi-
tive test charge (a proton) located at r. For the studied compounds, the V(r) values were 
calculated as described previously using Eq. (1).37 
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where ZA is the charge of nucleus A, located at RA, ρ(r') is the electronic density function of 
the molecular, and r' is the dummy integration variable. 
The MEP was realized by the Molekel program.38 
Chemometrics 
Principal component analysis (PCA). Given the great number of multivariate computed 
data, an exploratory tool is recommended to uncover unknown trends in the data and to reduce 
them. The central idea of PCA19 is to reduce the dimensionality of a data set consisting of 
large number of interrelated variables, while retaining, as much as possible, the variation 
present in the data set. This is achieved by transforming them into a new set of variables, the 
principle components (PCs), which are uncorrelated and ordered so that the first few retain 
most of the variation present in all of the original variables. The final result of PCA is the 
selection of a small number of descriptors (molecular properties) that are believed to be best 
related to the dependent variable, in this case, anticancer activity against HepG2-strains. 
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Hierarchical cluster analysis (HCA). The statistical analysis required in this study should 
group compounds of a similar kind into respective categories. HCA19 is a statistical method 
developed for this purpose. It is represented by a two dimensional diagram known as den-
drogram which illustrates the fusions or divisions made at each successive stage of the ana-
lysis. The single samples (compounds) are represented by the branches on the bottom of the 
dendrogram. The similarity among the clusters is given by the length of their branches so that 
compounds presenting low similarity have long branches whereas compounds of high simi-
larity have short branches.  
K-Nearest neighbor (KNN) method. The statistical technique KNN19 categorizes an un-
known object based on its proximity to samples already placed into categories. Specifically, 
the predicted class of an unknown object depends on the class of its K nearest neighbors, 
which accounts for the name of the technique. Classification with KNN is related to the 
compared distance among samples. Multivariate Euclidean distances between every pair of 
training samples are computed. After the model is built, a test set has its predicted class taking 
into account the multivariate distance of this sample with respect to the K samples in the 
training set. 
Soft independent modeling of class analogy (SIMCA) method. This method develops 
principal component models for each training set category. The main goal of SIMCA19 is the 
reliable classification of new samples. When a prediction is made in SIMCA, new samples 
insufficiently close to the PC space of a class are considered non-members. Additionally, the 
method requires that each training sample be pre-assigned to one of Q different categories, 
where Q is typically greater than one. It provides three possible outcome predictions: the 
sample fits only one pre-defined category, the sample does not fit any of the pre-defined 
categories and the sample fits into more than one pre-defined category. 
Stepwise discriminant analysis (SDA). SDA20,21 is also a multivariate method that at-
tempts to maximize the probability of correct allocation. This method has two main objec-
tives, which are to separate objects from distinct populations and to allocate new objects into 
populations previously defined. A stepwise procedure is used in this program, i.e., in each 
step, the most powerful variable is entered into the discriminant function. The criterion func-
tion for selecting the next variable depends on the number of specified groups.  
The SDA is a method based on the F-test for the significance of the variables. In each 
step, one variable is selected based on its significance and, after several steps, the more sig-
nificant variables are extracted from the whole set in question.  
Molecular Docking  
The geometry of the molecules 1–29 was optimized by the B3LYP/6-31G
 method 
while the geometry of the protein receptor was obtained from the Protein Data Bank (PDB) 
RCSB, identified by the code 1A8E,39 and optimized by the ROB3LYP/6-31G
 method. In 
order to better describe the biological environment involving the ligand/receptor interaction, 
only the protein fragment (iron atom and the amino acids bound to it: two tyrosines, one 
histidine, and one aspartic acid) of the transferrin was considered. The geometry of the 
complex was optimized through the molecular mechanics method with the force field MM+ 
implemented in the HyperChem 6.02 program and Polak Ribiere algorithms with a gradient of 
0.1 kcal Å-1 mol-1*. Flexible docking40 calculations were performed into a box. When using 
artemisinin (1), the dimensions of the box were x =18 Å, y =18 Å and z=18 Å and the number 
of molecules of water was 193, while for the other compounds (2–29) the dimensions were 
                                                                                                                    
* 1 kcal = 4.184 kJ 
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x=20 Å, y=20 Å and z=29.3 Å and the number of molecules of water was 388. For the 
simulation involving the complex, the peroxide group (pharmacophore) of artemisinin and its 
derivatives was positioned toward the iron fragment of the receptor in order to achieve a good 
interaction. 
RESULTS AND DISCUSSION 
Method and basis set for the description of the geometries of artemisinin 
and its derivatives 
The theoretical and experimental parameters of the 1,2,13-trioxane ring in 
artemisinin are given in Table I. They were used with the objective to identify, 
through PC and HC analyses, which geometry optimization method/basis set give 
results closest to the experimental data. The advantage in using the PCA and 
HCA methods in this step of this study was that all structural parameters are con-
sidered simultaneously and it takes into account the correlations among them. 
The first three PCs explain 83.8 % of the original information as follows: 
PC1 = 38.73, PC2 = 28.8 and PC3 = 16.3 %. The PC1–PC2 scores plot is shown 
in Fig. 2a, from which it can be see that the methods are discriminated into two 
classes according to PC1. The semi-empirical methods (AM1 and PM3) are on 
the right side; while the other theoretical (HF and B3LYP) and experimental 
methods are on the left side. Moreover, it can be seen that the B3LYP/6-31G
 
and B3LYP/6-31G
 method are the closest to the experimental method, indi-
cating that either of them could be used in the development of this study. 
TABLE I. Theoretical and experimental parameters of the 1,2,4-trioxane ring in artemisinin 
(1) 
Geometry HF/3-21G HF/6-31G HF/ 
/6-31G

HF/ 
/6-31G
 
HF/ 
/CEP31G 
HF/ 
/CEP/31G
 
O1–O2 1.462  1.447  1.390  1.390  1.439  1.395 
O3–C3 1.441  1.435  1.396  1.396  1.447  1.405 
C3–O13 1.436  1.435  1.408  1.409  1.449  1.418 
O13–C12 1.408  1.403  1.376  1.376  1.413  1.384 
C12–C12a 1.529  1.533  1.532  1.532  1.549  1.542 
O1–O2 1.462  1.447  1.390  1.390  1.439  1.395 
O1–O2–C3 107.089  108.799  109.458  109.460  109.383  109.452 
O2–C3–O13 107.274  106.762  107.841  107.818  106.771  108.011 
C3–O13–C12 115.684  117.294  115.292 115.309 116.781  114.800 
O13–C12–C12a 112.092  112.289 112.268  112.263  112.462  112.473 
C12–C12a–O1 111.600  110.964  110.540  110.545  110.588  110.539 
C12a–O1–O2 111.296  113.233  112.701  112.700  113.386  112.506 
O1–O2–C3–O13 –74.701  –71.865  –73.369  –73.377  –71.992  –73.783 
02–C3–O13–C12 32.363  33.414 31.034  31.058  32.955  31.026 
C3–O13–C12–C12a 28.188  25.285 27.432  27.402  25.432  27.538 
O13–C12–C12a–O1 –50.771  –49.377 –50.157  –50.143  –49.683  –50.321 
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TABLE I. Continued 
Geometry HF/3-21G HF/6-31G HF/ 
/6-31G

HF/ 
/6-31G
 
HF/ 
/CEP31G 
HF/ 
/CEP/31G
 
C12–C12a–O1–O2 9.941  12.486  10.918  10.924  12.683  10.721 
C12a–O1–O2–C3 50.358  46.723  48.670  48.674  46.638  48.892 
 
Geometry B3LYP/3-21G B3LYP/6-31G  B3LYP/6-31G
 B3LYP//6-1G
 
O1–O2 1.524  1.525  1.460  1.460 
O3–C3 1.456  1.456  1.414  1.414 
C3–O13 1.473  1.473  1.441  1.441 
O13–C12 1.431  1.426  1.396  1.396 
C12–C12a 1.535  1.538  1.539  1.539 
O1–O2 1.524  1.525  1.460  1.460 
O1–O2–C3 105.587  107.304  108.267  108.286 
O2–C3–O13 108.226  107.739  108.490  108.494 
C3–O13–C12 113.194  114.993  114.095  114.067 
O13–C12–C12a 113.302  113.644 113.261 113.242 
C12–C12a–O1 112.413  111.751  111.308  111.285 
C12a–O1–O2 109.627  111.405  111.609  111.595 
O1–O2–C3–O13 –76.620 –73.463  –73.937  –73.913 
02–C3–O13–C12 33.756  34.982  32.863  32.782 
C3–O13–C12–C12a 29.076  26.258  27.383  27.507 
O13–C12–C12a–O1 –52.217  –51.204  –51.197  –51.344 
C12–C12a–O1–O2 9.625  12.763  11.692  11.784 
C12a–O1–O2–C3 51.056  46.885  47.879  47.835 
 
Geometry B3LYP/CEP31G B3LYP/CEP31G
 AM1 PM3 EXP48 
O1–O2 1.515  1.468  1.289  1.544  1.469(2) 
O3–C3 1.475  1.427  1.447  1.403  1.416(3) 
C3–O13 1.488  1.452  1.427  1.428  1.445(2) 
O13–C12 1.440  1.406  1.416  1.403  1.379(2) 
C12–C12a 1.559  1.551 2.220  1.555  1.523(2) 
O1–O2 1.515  1.468  1.289  1.544  1.469(2) 
O1–O2–C3 107.961  108.381 112.530  110.339  108.100(1) 
O2–C3–O13 107.602  108.566 103.615  104.815  106.600(2) 
C3–O13–C12 114.883  113.886 115.479  116.005  114.200(2) 
O13–C12–C12a 113.722  113.457 113.502  115.205  114.500(2) 
C12–C12a–O1 111.510  111.322 111.057  113.177  110.700(2) 
C12a–O1–O2 111.739  111.573  113.736  112.289  111.200(2) 
O1–O2–C3–O13 –73.439 –74.064 –77.795  –73.301  –75.500(2) 
02–C3–O13–C12 34.923  33.258  42.001 52.699  36.000(2) 
C3–O13–C12–C12a 25.587  26.926 11.490  2.817  25.3000(2) 
O13–C12–C12a–O1 –51.007  –51.184 –41.826  –40.526  –51.300(2) 
C12–C12a–O1–O2 13.020  11.945 12.049  19.968  12.700(2) 
C12a–O1–O2–C3 46.466  47.496  47.069  35.602  47.800(2) 
HCA was also used to investigate the most appropriate method for further 
calculation. Analyzing the dendrogram obtained by HCA with complete linkage 
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method in Fig. 2b, it can concluded that the theoretical methods are distributed in 
a similar way as in PCA, i.e., HC analysis confirmed the PC analysis results. 
Therefore, according to the obtained results, the B3LYP in combination with either 
of the 6-31G
 and 6-31G
 basis sets can be used to model the molecular struc-
ture of the studied compounds. In this study, the B3LYP/6-31G
 method was 
used. 
 
Fig. 2. PC1–PC2 scores plot (a) and dendrogram (b) of the fourteen theoretical and 
experimental methods used in the geometry optimization of artemisinin. 
Molecular electrostatic potential maps 
The MEP maps for artemisinin and the derivatives given in Fig. 1 were simi-
lar (Fig. 3). They display contour surfaces close to that of the 1,2,13-trioxane 
ring, which is characterized by negative electrostatic potentials (red and green co-
lors), on which the lowest value for the charge was about –0.11 a.u. (red color). 
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Such a characteristic indicates concentration of the electron density due to the 
lone electron pairs on the oxygen atoms (O1, O2 and O13). These molecules also 
have contour surfaces characterized by positive electrostatic potentials (blue), 
whereby the highest value was about 0.049 a.u. The distribution of electron den-
sity on the molecules around the trioxane ring induces their cytotoxicity against 
cancer, a belief supported by the fact that the complexation of artemisinin with 
transferrin involves particularly the interaction between the peroxide bond, the 
most negatively charged region on the ligand, and the iron(II) ion, the most posi-
tive zone on the transferring, the receptor, molecule.41–43 Hence, the presence of 
a surface in red near to 1,2,13-trioxane ring suggests artemisinin and derivatives 
have a reactive site for electrophilic attack and must possess anticancer cytotoxi-
city; consequently, they are of interest for investigation. Thus, in the case of an 
electrophilic attack of the iron of transferrin against an electronegative region of 
the studied compounds, this attack has a great preference to occur through the in-
volvement of the endoperoxide linkage. A pattern of MEP maps is an indication 
that the artemisinin and derivatives in Fig. 1 are all active against cancer. Thus, 
by analyzing MEP maps, the selection of inactive compounds is avoided in the 
proposition step of potential new active derivatives against cancer HepG2. 
 
Fig. 3. MEP (a.u.) Maps of artemisinin (1) and derivative compound 7 
with anticancer HepG2 activity. 
PCA Method 
The PCA results show the score plot relative to the first and second principal 
components. In PC1, there is a distinct separation of the compounds into two 
classes (Fig. 4): more and less active. More active compounds are on the left 
side, while less active are on the right side. The variables responsible for this 
were ALOGPS_logs, Mor29m, IC5 and gap energy. They were chosen from the 
complete data set (1740 descriptors) and they are assumed to be very important 
in the investigation the anticancer mechanism involving artemisinins. Other vari-
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ables were not selected because either they had a poor linear correlation with 
activity or they did not give a distinct separation between the more and less ac-
tive compounds. The values for these properties are listed in Table II. The first 
three principal components, PC1,  PC2 and PC3 explained 42.97, 28.72 and 
14.94 % of the total variance, respectively. According to Table III, the Pearson 
correlation coefficient between the variables was, in general, low (less than 0.50, 
in absolute values). 
 
Fig. 4. Plot of the first two principal components score vectors (PC1×PC2) for the separation 
of artemisinin and the derivatives into two classes: (+) more active compounds 
and (–) less active compounds against HepG2 cancer. 
TABLE II. Values of the four properties that classify artemisinin and the derivatives and 
values of experimental IC50 
Compound  ALOGPS_logs Mor29m  IC5  Gap energy, a.u. IC50 / μM  Activity
 
1  –2.3500 –0.3050  4.8620  0.2616  97  la
a 
2  –3.5200 –0.3070  5.2530  0.2525  >100  la 
3  –5.0300 –0.4120  5.5140  0.2522  17.6  ma
b 
4  –5.7600 –0.4430  5.6280  0.2522  9.5  ma 
5  –6.3500 –0.4550  5.6840  0.2521  2.8  ma 
6  –6.8400 –0.5250  5.6240  0.2524  1.2  ma 
7  –7.1600 –0.5140  5.5010  0.2527  0.46  ma 
8  –7.3900 –0.5150  5.3640  0.2524  0.79  ma 
9  –7.4900 –0.5010  5.2250  0.2525  4.2  ma 
10  –3.6400 –0.2360  5.2170  0.2467  >100  la 
11  –7.0300 –0.5260  5.5970  0.2462  0.72  ma 
12  –7.6800 –0.1790  5.1970  0.2462  >100  la 
13  –3.6800 –0.3650  5.2530  0.2367  >100  la 
14  –3.6800 –0.3050  5.2530  0.2359  >100  la 
15  –6.9700 –0.3940  5.5080  0.2457  2.8  ma 
16  –6.9700 –0.2910  5.5080  0.2552  4.4  ma 
17  –7.4000 –0.2280  5.1590  0.2217  >100  la 
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TABLE II. Continued 
Compound  ALOGPS_logs Mor29m  IC5  Gap energy, a.u. IC50 / μM  Activity
 
18  –7.4000 –0.2280  5.1590  0.2287  >100  la 
19  –3.7500 –0.4430  5.1800  0.2194  >100  la 
20  –7.1401 –0.3051  5.5711  0.2197  1.4  ma 
21  –7.6100 –0.3330  5.1680  0.2177  >100  la 
22  –6.0300 –0.3110  5.5720  0.2524  1.8  ma 
23  –5.4900 –0.3470  5.6380  0.2199  42.3  ma 
24  –4.8200 –0.5180  5.8560  0.2517  3.5  ma 
25  –6.7200 –0.5520  5.5430  0.2491  1.3  ma 
26  –7.0600 –0.5520  5.4190  0.2492  0.77  ma 
27  –7.3500 –0.6010  5.2800  0.2276  0.74  ma 
28  –6.8400 –0.5150  5.5160  0.2449  3.7  ma 
29  –7.0100 –0.5430  5.4880  0.2323  0.47  ma 
aThe less active compound; 
bThe more active compound 
TABLE III. Correlation matrix for the descriptors 
  ALOGPS_logs Mor29m  IC5 
Mor29m  0.251 –  – 
IC5  –0.269 –0.464  – 
Gap energy  0.152  –0.207  0.203 
The loading plot relative to the first and second principal components can be 
seen in Fig. 5. PC1 is expressed in Eq. (2) as a function of the four selected 
descriptors. Thus, it is a quantitative variable that provides the overall predictive 
ability of the different sets of molecular descriptors for all the selected properties. 
The loadings of ALOGPS_logs and Mor29m are positive whereas they are nega-
tive for IC5 and gap energy. Incidentally, gap energy is the least important pro-
 
Fig. 5. Plot of the first two principal components loadings vectors (PC1×PC2) for the four 
descriptors responsible for the separation of the artemisinin and the derivatives into two 
classes: (+) more active compounds and (–) less active compounds against HepG2 cancer. 
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perty contributing to PC1, as its coefficient (–0.272) is lower in comparison to 
those of the others. For a compound to be more active against cancer, it must ge-
nerally have a combination of these properties, i.e., more negative values for 
ALOGPS_logs and Mor29m but more positive values for Gap energy and IC5. 
PC1 = 0.393ALOGPS_logs + 0.619Mor29m – 0.624 IC5 – 0.272Gap energy  (2) 
HCA Method 
The HCA method that better classified the compounds into two classes 
(more and less active compounds) was the complete method. In the complete 
linkage, the distance between two clusters is the maximum distance between a 
variable in one cluster and a variable in the other cluster. The descriptors em-
ployed to perform HCA were the same as for PCA, i.e., ALOGPS_logs, Mor29m, 
IC5 and gap energy. The dendrogram (Fig. 6) shows HCA graphic as well as the 
compounds separated into two main classes. The scale of similarity varies from 0 
for samples with no similarity to 100 for samples with identical similarity. By 
analyzing the dendrogram, some conclusions can be made even though the 
compounds present some structural diversity. 
 
Fig. 6. HCA Dendrogram for artemisinin and the derivatives with anti-HepG2 cancer activity. 
The more active analogs are distributed into clusters a and b. They have both 
a six-membered ring artemisinin and a five-membered ring artemisinin analogs 
and substituents with a greater number of carbon atoms. The number of amides in 
clusters a and b (more active analogues) is eleven, while in clusters c and d (less 
active analogues), it is only one. The values for IC5 are the highest (IC5 > 5.20) 
and for Mor29m they are the most negative. The variation in activity is the great-
est in cluster a (IC50 = 0.47 μM, for 29, and IC50 = 42.3 μM, for 23). This cluster 
also presents the lowest values for gap energy among the most active com-
pounds. 
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The less active class was divided into two main clusters (c and d). All samp-
les, excluding 1, present a six-membered ring artemisinin. These two clusters 
have a clear difference involving values for ALOGPS_logs (cluster c, –7.40 to 
–7.68; cluster d, –2.35 to –3.75) and Mor29m (cluster c, –0.179 to 0.333, which 
are the lowest of all compounds; cluster d, –0.236 to –0.443). Since artemisinin 
(1) is found to bear different substitution from the others structures, it was clas-
sified alone. It shows the lowest negative value for ALOGPS_logs and the lowest 
positive value for IC5 (–2.35). Cluster c contains ester 12, alcohols 17 and 18 
(isomers), and ketone 21. These compounds bear a long carbon chain of C18H37. 
Samples in cluster d are amide 2, ester 10, alcohols 13 and 14 (isomers), and 
ketone 19. They bear a short carbon chain, C2H5 (the exception is 1). 
Interestingly, alcohols with a C12H25 carbon chain developed cytotoxicities 
much higher than alcohols with a short C2H5 carbon chain or with a long C18H37 
carbon chain. Moreover, ketones with C8H17 and C12H25 carbon chains were 
much more active than ketones with a short C2H5 carbon chain or a long C18H37 
carbon chain. Moreover, as the length of the carbon chain of the six-membered 
ring amides increased, the activity increased from 2 (C2H5, IC50 = 100 μM) through 
3 (C6H13, IC50 = 17.6 μM), 4 (C8H17, IC50 = 9.5 μM), 5 (C10H21, IC50 = 2.8 
μM), 6 (C12H25, IC50 = 1.2 μM) to 7 (C14H29, IC50 = 0.46 μM). Further in-
creases in the carbon chain length resulted in slight drops in the cytotoxicity as 
can be noted for 8 (C16H33, IC50 = 0.79 μM) and 9 (C18H37, IC50 = 4.2 μM). For 
the five-membered ring amides, as the length of carbon chains increased, the 
activity increased slightly from 25 (C12H25, IC50 = 1.3 μM), 26 (C14H29, IC50 =  
= 0.77 μM) to 27 (C16H33, IC50 = 0.74 μM). 
KNN Method 
The results obtained with the KNN method using one to eight (K = 1 to K =  
= 8) nearest neighbors are given in Table IV and the same was used for vali-
dation of the initial set (Fig. 1). For K = 1, 2, 4, 6 and 8, the percentage correct 
information was 100 % but 8NN was used because the higher the number of 
nearest neighbors, the better the reliability of the method in question. 
TABLE IV. Classification obtained with the KNN method 
Category  Number of 
compounds
Compounds incorrectly classified 
1NN 2NN 3NN 4NN 5NN 6NN 7NN 8NN 
Class:  more  active  19  0 0 1 0 1 0 0 0 
Class: less active  10  0  0  0  0  0  0  1  0 
Total  29  0 0 1 0 1 0 1 0 
% Correct information  –  100  100  96.36 100  96.36 100  96.36  100 
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SIMCA Method 
The results obtained with the SIMCA method are given in Table V. The me-
thod was also used for validation of the initial set (Fig. 1). For the 19 more active 
compounds, one was incorrectly classified. The model was built with three PCs 
for the more active class and two PCs for the less active class. 
TABLE V. Classification obtained by using SIMCA method 
Category  Number of compounds  Correct classification 
Class: more active  19  18 
Class: less active  10  10 
Total 29  29 
% Correct information  –  96.5 
SD Analysis 
From the two-discrimination function obtained with the SDA study, it can 
see that the variables ALOGPS_logs, MOR29m, IC5 and Gap energy have a large 
contribution in the classification methodology. According to the results using 
PCA, HCA, KNN, SIMCA and SDA, it can also be seen that the descriptors are 
key properties for explaining the anticancer HepG2 activity of the derivatives 
compounds artemisinin (Fig. 1).  
The discrimination functions for the more active and less active groups are 
given, respectively, by Eqs. (3a) and (3b). 
Group more active: 
 –1.28–1.18ALOGPS_logs – 1.45Mor29m + 2.27IC5 + 0.772Gap energy (3a) 
Group less active: 
  –4.64 + 2.23ALOGPS_logs + 2.75Mor29m – 4.32IC5 – 1.47Gap energy   (3b) 
Through the discrimination functions and the value of each variable for the 
compounds and using all compounds of the training set, the classification is ob-
tained (Table VI). The classification error rate was 0 %, resulting in a satisfactory 
separation of the more and less active compounds. The allocation rule derived 
from the SDA results, when the activity against cancer of new artemisinin deri-
vative is investigated, is: a) initially, for the new derivatives, calculate the value 
of the more important variables obtained in the construction of the SDA model 
(descriptors); b) substitute these values in the two discrimination functions per-
formed in this work; c) check which discrimination function (group more active 
compounds or group less active compounds) presents the higher value. The new 
derivative is more active if it is related to the discrimination function of the more 
active group and vice versa. 
To determine if the model obtained is reliable, a cross-validation test which 
uses the leave-one-out technique was employed. In this procedure, one com-
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pound is omitted from the data set and the classification functions are built based 
on the remaining compounds. 
TABLE VI. Classification matrix obtained using SDA 
Classification group or class  Number of compounds 
True group 
More active  Less active 
Group (Class): more active  19  19  0 
Group (Class): less active  10  0  10 
Total 29  –  – 
% Correct information  –  100  100 
Afterwards, the omitted compound is classified according to the classifica-
tion functions generated. In the next step, the omitted compound is included and 
a new compound is removed, and the procedure continues until the last com-
pound is removed. The obtained results with the cross-validation methodology 
are summarized in Table VII. 
TABLE VII. Classification matrix obtained by using SDA with cross validation 
Classification group or class  Number of compounds 
True group 
More active  Less active   
Group (Class): more active  19  19  0   
Group (Class): less active  10 0  10   
Total 29  –  –   
% Correct information  –  100  100   
In the application of the chemometric step in this study, it was verified that 
the most important properties to describe the anticancer activity are: 
ALOGPS_logs, Mor29m, IC5 and gap energy. Thus, some considerations on the 
most important variables can be drawn for activity from molecules. The 
ALOGPS_logs indicates that drug solubility is one of the important factors, 
which affect the movement of a drug from the site of administration into the 
blood. Knowledge of drug solubility is important. It is well-known that insuf-
ficient solubility of a drug can lead to poor absorption.44 From Table II, it can be 
seen that aqueous solubility is lower for the more active compounds than for the 
less inactive ones. This is an indication that the lipophilic carbon chain plays an 
important role in determining the cytotoxicities of the more active compounds.  
The Mor29m is the 3D-MORSE (Molecule representation of structures based 
on electron diffraction) code of signal 29, weighted with atomic masses. It is cal-
culated by summing atom weights viewed by a different angular scattering func-
tion. The 3D-MORSE code allows the representation of the three dimensional 
structure of a molecule by a fixed number of values.45 This fact indicates the 
importance of atomic mass, a steric property, and gives the basic idea that the 
larger the molecule is, the higher is the activity, because the activity also in-
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creases with decreasing value of Mor29m. In fact, the less active compounds 
(Table II), 12,  17 and 18, have Mor29m values of –0.1790 and –0.2280, 
respectively, and the more active compounds, 7, 8, 11, 26, 27 and 29, present va-
lues of –0.5140, –0.5150, –0.5260, –0.5520, –0.6010 and –0.5430, respectively. 
It seems clear that larger compounds present a bigger steric effect, augmenting 
the anticancer activity as consequence of the augmented lipophilicity.  
The information content index is calculated based on the pair-wise equiva-
lence atoms in a hydrogen-filled molecule.46 In Table III, in general, compounds 
with higher values for IC5 are more active. These compounds are the same that 
have a lipophilic carbon chain. 
The gap energy is the energy separation between the LUMO and HOMO 
energies.47 This property gives information associated to the electronic structure 
of a molecule and is the measure of the stability of a molecule. A smaller gap 
energy shows that a molecule is more reactive. In TABLE III, as can be seen, 
when the gap energy values of the more active and less active compounds are 
compared, it is not possible to verify a clear tendency for their distinction. This 
can be associated to the smaller contribution of this property in PC1 (Eq. (2)). It 
is possible that the main contribution to a higher anticancer activity against 
HepG2 developed by a compound is due to its lipophilicity. 
Molecular docking 
Docking calculations for the compounds from Fig. 1 show that the polar 
region of the ligands close to the peroxide linkage is directed toward the iron ion 
of the receptor. The results achieved for the interaction of artemisinin (1) and 
compound 7 with the receptor are presented in Fig. 9. For artemisinin, the Fe–O1 
(7) 
(1) 
Fig. 9. Docking formed for artemisinin (1) 
and the molecule receptor and derivative 7 
and the molecule receptor (transferrin). 
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and Fe–O2 distances are 2.52 and 2.74 Å, respectively. However, for 7, they are 
2.85 e 3.48Å, respectively. The explanation for a closer approximation of the 
artemisinin to the iron ion (Fe2+) is probably due to the greater number of bulky 
substituents in the artemisinin derivative, which makes it difficult to approach the 
transferrin. Another point to emphasize is that the anticancer activity of the 
derivatives is probably also related to lipophilicity owing to the great number of 
carbon atoms present in the molecule, besides the endoperoxide group.48 The 
histidine unity in transferrin is usually coordinated to the iron ion through its sp2 
the nitrogen atom. This allows for the iron ion to acquire a hexacoordinated 
octahedral arrangement after binding to the artemisinin and the derivatives.49  
CONCLUSIONS 
In this work, the use PCA and HCA in the selection step of the method and 
the basis set for the molecular modeling and development of quantum chemistry 
calculations revealed that the B3LYP/6-31G
 and B3LYP/6-31G
 theory were 
the most adequate. The use of MEP maps to identify key structural features of the 
artemisinin and its derivatives necessary for their activities and to investigate the 
interaction with the molecular receptor (transferrin) showed that the presence of a 
red surface near to the 1,2,13-trioxane ring suggested that these compounds have 
a reactive site for electrophilic attack and they must possess anticancer cytoto-
xicity and which in the case of the an electrophilic attack of the ion of tranferrin 
against an electronegative region of the studied compounds, this attack has a 
great preference to occur through the involvement of the endoperoxide linkage. 
Principal component analysis (PCA), hierarchical cluster analysis (HCA), the 
K-nearest neighbor method (KNN), soft independent modeling of class analogy 
method (SIMCA) and the stepwise discriminant analysis showed that the studied 
artemisinin and derivatives can be classified into two classes or group: more ac-
tive and less active according to their degree of anticancer HepG2 activity. The 
properties ALOGPS_logs, Mor29m, IC5 and gap energy are responsible for the 
separation into the more active and less active studied molecules and it is inte-
resting to notice that these properties represent three distinct classes of interac-
tions between the molecules and the transferring receptor: electronic (gap ener-
gy), steric (Mor29m and IC5) and hydrophilic (ALOGPS_logs). The molecular 
docking study showed that the ligands approached the receptor (transferrin) 
through the endoperoxide bond. The developed studies with MEP maps, PCA, 
HCA, KNN, SIMCA and SDA and molecular docking can provide valuable 
insight into the experimental process of syntheses and biological evaluation of 
new artemisinin derivatives with activity against cancer HepG2. 
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МОЛЕКУЛСКО МОДЕЛОВАЊЕ И ХЕМОМЕТРИЈСКЕ СТУДИЈЕ 
АНТИКАНЦЕР ДЕРИВАТА АРТЕМИЗИНИНА 
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3 
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Naturais, Universidade Federal do Pará, CP 101101, CEP 66075-110 Belém, PA, Amazônia, 
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Farmácia, Instituto de Ciências da Saúde, Universidade Federal do Pará, CP 101101, CEP 66075-110 Belém, 
PA и 
3Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, 
CEP 65085-580 São Luis, MA, Brasil 
Изложени су резултати молекулског моделовања и мултиваријантне студије која обу-
хвата артемизинин и 28 његових деривата, који делују против хуманог хепатоцелуларног 
карцинома HepG2. Израчунавања су вршена на нивоу теорије B3LYP/6-31G
. Коришћене 
су MEP мапе да би се идентификовали структурни детаљи у артемизинину и његовим дери-
ватима, неопходни за њихову активност. Примењене су хемометријске методе PCA, HCA, 
KNN, SIMCA и SDA да би се установило који подскуп варијабли највише одговара за пред-
виђање  антиканцерогене  активиности. Хемометријска  разматрања  су  показала  да  су 
LOGPS_logs, Mor29m, IC5 и gap energy дескриптори одговорни за разликовање између ак-
тивних и мање активних једињења. Такође је примењено молекулско доковање да би се ис-
тражила интеракција између лиганда и рецептора. Резултати показују да се лиганд везује за 
рецептор преко ендопероксидне везе. 
(Примљено 27. децембра 2010) 
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